Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors
Work
Year: 2023
Type: article
Abstract: Pembrolizumab significantly improves clinical outcomes in advanced/metastatic microsatellite instability high (MSI-H)/deficient mismatch repair (dMMR) solid tumors but is not well studied in the neoad... more
Source: Journal of Clinical Oncology
Institutions The University of Texas MD Anderson Cancer Center, Sidney Kimmel Comprehensive Cancer Center
Cites: 38
Cited by: 109
Related to: 10
FWCI: 46.02
Citation percentile (by year/subfield): 99.99
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: green